Description
Vialox Peptide
Vialox, also known as pentapeptide‑3V, is a synthetic peptide molecule with the amino acid sequence Gly‑Pro‑Arg‑Pro‑Ala (GPRPA). It is believed to interact with neuronal nicotinic acetylcholine receptors located in the postsynaptic membrane of muscle cells, which are responsible for transmitting signals from nerve cells to muscle cells. By potentially reducing the binding of acetylcholine at these receptors, Vialox may relax muscle contraction mechanisms in experimental models, which can affect wrinkle depth and skin texture in topical research scenarios.
Chemical Makeup
Molecular Formula: C₁₁H₃₇N₉O₅
Molecular Weight: 495.58 g/mol
Other Known Titles: Pentapeptide‑3V, SCHEMBL1552457, HY‑P0099, ZINC35922739
Research and Experimental Context
Vialox Peptide Mechanism of Action
Vialox is suggested by researchers to act as a competitive antagonist at nicotinic acetylcholine receptors on the postsynaptic membrane of muscle cells. In laboratory studies, competitive antagonists can block receptor binding sites and reduce the ability of acetylcholine to trigger sodium ion channel opening and downstream muscle contraction signaling in controlled experimental models. This mechanism is similar in concept to how compounds like tubocurarine interact with nicotinic receptors.
Vialox and Skin Topography
Some experimental work has focused on how Vialox may influence skin surface topography by affecting localized muscle relaxation patterns. In controlled laboratory settings, peptides that disrupt neuromuscular transmission have been associated with reduced contraction‑associated lines and smoother surface texture in tissue models.
Vialox peptide is available for research and laboratory purposes only. Please review and adhere to the site’s Terms and Conditions before ordering.
